Anti-COX8C monoclonal antibody

Pre-made anti-COX8C monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to COX8C/COX8C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0605-Ab-1/ GM-Tg-hg-IP0605-Ab-2Anti-Human COX8C monoclonal antibodyHuman
GM-Tg-rg-IP0605-Ab-1/ GM-Tg-rg-IP0605-Ab-2Anti-Rat COX8C monoclonal antibodyRat
GM-Tg-mg-IP0605-Ab-1/ GM-Tg-mg-IP0605-Ab-2Anti-Mouse COX8C monoclonal antibodyMouse
GM-Tg-cynog-IP0605-Ab-1/ GM-Tg-cynog-IP0605-Ab-2Anti-Cynomolgus/ Rhesus macaque COX8C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0605-Ab-1/ GM-Tg-felg-IP0605-Ab-2Anti-Feline COX8C monoclonal antibodyFeline
GM-Tg-cang-IP0605-Ab-1/ GM-Tg-cang-IP0605-Ab-2Anti-Canine COX8C monoclonal antibodyCanine
GM-Tg-bovg-IP0605-Ab-1/ GM-Tg-bovg-IP0605-Ab-2Anti-Bovine COX8C monoclonal antibodyBovine
GM-Tg-equg-IP0605-Ab-1/ GM-Tg-equg-IP0605-Ab-2Anti-Equine COX8C monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0605-Ab-1/ GM-Tg-hg-IP0605-Ab-2; GM-Tg-rg-IP0605-Ab-1/ GM-Tg-rg-IP0605-Ab-2;
GM-Tg-mg-IP0605-Ab-1/ GM-Tg-mg-IP0605-Ab-2; GM-Tg-cynog-IP0605-Ab-1/ GM-Tg-cynog-IP0605-Ab-2;
GM-Tg-felg-IP0605-Ab-1/ GM-Tg-felg-IP0605-Ab-2; GM-Tg-cang-IP0605-Ab-1/ GM-Tg-cang-IP0605-Ab-2;
GM-Tg-bovg-IP0605-Ab-1/ GM-Tg-bovg-IP0605-Ab-2; GM-Tg-equg-IP0605-Ab-1/ GM-Tg-equg-IP0605-Ab-2
Products NameAnti-COX8C monoclonal antibody
Formatmab
Target NameCOX8C
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-COX8C monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0605-Ag-1Recombinant multi-species COX8C/ COX8-3 protein


    Target information

    Target IDGM-IP0605
    Target NameCOX8C
    Gene ID341947,75483,360229,106996000,100300759,111770393
    Gene Symbol and Synonyms1700007F21Rik,COX8-3,COX8C,COXVIII-3,LOC100300759,LOC106996000,LOC111770393
    Uniprot AccessionQ7Z4L0,Q7TNN2
    Uniprot Entry NameCOX8C_HUMAN,COX8C_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000187581
    Target ClassificationN/A

    The target: COX8C, gene name: COX8C, also named as COX8-3. Predicted to be involved in mitochondrial electron transport, cytochrome c to oxygen. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.